Cardiovascular changes in renal failure

Karin Tyralla1, Kerstin Amann

  • 1Department of Pathology, University of Erlangen, Germany.

Blood Purification
|September 11, 2002
PubMed

Insights

Patients with renal failure face a significantly higher risk of cardiovascular complications, with cardiac death being the leading cause. This review details the structural heart and blood vessel changes contributing to this increased risk.

Area of Science:

  • Nephrology
  • Cardiology
  • Pathology

Background:

  • Cardiovascular complications are a major clinical issue in renal failure patients.
  • Cardiac death is the primary cause of mortality in this population.
  • Uremic patients exhibit a 20-fold increased cardiac risk compared to the general population.

Purpose of the Study:

  • To review the structural cardiac and vascular changes in renal failure.
  • To explore the functional repercussions of these changes on cardiovascular health.
  • To elucidate the contribution of these abnormalities to high cardiovascular morbidity and mortality.

Main Methods:

  • Literature review focusing on structural and metabolic abnormalities of the myocardium and vasculature in renal failure.
  • Analysis of the impact of these changes on cardiovascular function.
  • Synthesis of evidence linking structural changes to clinical outcomes.

Main Results:

  • Renal failure is associated with well-documented structural and metabolic abnormalities in the heart.
  • These cardiac abnormalities include changes in the myocardium and vasculature.
  • These structural alterations significantly impact cardiovascular function.

Conclusions:

  • Structural changes in the heart and vasculature are key contributors to cardiovascular morbidity and mortality in renal failure.
  • Understanding these changes is crucial for managing cardiovascular risk in these patients.
  • Further research into mitigating these structural abnormalities could improve patient outcomes.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...